Drugs / Hepatitis A Virus
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | EU (EMA) | Twinrix Adult | — | 1996-09-19 | europa.eu ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT00806195 Background | Dec 2008 → Mar 2011 | meningitis, meningococcal infection | Novartis | Completed | No outcome recorded |
| — | NCT00050921 Background | ? → Mar 2005 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hepatitis A Virus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00806195 ↗ |
| Known as | Hepatitis A virus, inactivated | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00050921 ↗ |
| Modality | Vaccine | “hepatitis A vaccination” NCT00050921 ↗ |